Navigation Links
MedCath Announces Extension of Tolling Agreement With U.S. Department of Justice

CHARLOTTE, N.C., Nov. 19, 2012 /PRNewswire/ -- MedCath Corporation announced today that it has extended its Tolling Agreement with the U.S. Department of Justice (the "DOJ") until April 30, 2013. The Tolling Agreement, which expired October 31, 2012, tolls or suspends the statute of limitations for allegations related to the DOJ's industry-wide investigation of implantable cardioverter defibrillator ("ICD") implantations. The DOJ requested that MedCath extend the Tolling Agreement until April 30, 2013 as the DOJ continues its investigation of the hospital industry's compliance with Medicare coverage requirements for ICD procedures. MedCath continues to cooperate with the investigation.

About MedCath
MedCath Corporation, headquartered in Charlotte, N.C., was a health care provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. Having now divested all of its hospitals and filed for dissolution, MedCath is focused on realizing the value of its remaining immaterial assets, making tax and regulatory filings, winding down its business affairs, managing its known and unknown contingencies, and seeking to make distributions, if any, to its stockholders as part of its plan of dissolution.

SOURCE MedCath Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cord Blood America Announces 3rd Quarter and Nine Months 2012 Financial Results
2. IntelliCell BioSciences Announces It Will Present and Run Workshop at the 10th Annual Commercialization of Regenerative Medicine in London
3. Egenix, Inc. Announces New Director, John Reid
4. The Trendlines Group Announces Co-development Agreement with Endo
5. BioLife Solutions Announces 2012 Third Quarter Results: Ninth Straight Quarter of Record Revenue
6. Sapio Sciences Announces Exemplar LIMS for Tablet Computers
7. SomaGenics Announces Issue of Key Patent for Its sshRNA Technology and Receipt of Two New Small Business Innovation NIH Grants
8. Karyopharm Therapeutics Announces Oral Presentation at the American College of Rheumatology (ACR) on the use of Selective Inhibitors of Nuclear Export (SINE) CRM1 Antagonists in preclinical models of Systemic Lupus Erythematosus (SLE)
9. AstraZeneca Announces Top-line Phase III Results from Naloxegol Pivotal Trials In Patients With Opioid-Induced Constipation
10. China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
11. Apexigen Announces Initiation of Clinical Trials By Its Partner, Simcere Pharmaceutical Group
Post Your Comments:
(Date:11/24/2015)... Switzerland (PRWEB) , ... November 24, 2015 , ... ... plant and the environment are paramount. Insertion points for in-line sensors can represent ... has developed the InTrac 781/784 series of retractable sensor housings , which ...
(Date:11/24/2015)... , Nov. 24, 2015 HemoShear ... on discovering drugs for metabolic disorders, announced today ... to its Board of Directors (BOD). Mr. Watkins ... of Human Genome Sciences (HGS), and also served ... Jim Powers , Chairman and CEO ...
(Date:11/23/2015)... , Nov. 24, 2015 Women with a ... CT exams face a higher risk of lung cancer than ... presented next week at the annual meeting of the Radiological ... --> --> Lung nodules ... classified as solid or subsolid based on their appearance on ...
(Date:11/23/2015)... The royalty-free a greement a llows ... 112 low- and m iddle-i ncome ... --> The Medicines Patent Pool (MPP) today announced its ... with Bristol-Myers Squibb for daclatasvir, a novel direct-acting antiviral that ... virus.  The royalty-free licence will enable generic manufacture of daclatasvir ...
Breaking Biology Technology:
(Date:11/18/2015)... , Nov. 18, 2015  As new scientific discoveries ... doctors and other healthcare providers face challenges in better ... and patients. In addition, as more children continue to ... patient,s adulthood and old age. John M. ... Children,s Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... Nov. 17, 2015  Vigilant Solutions announces today that ... Board of Directors. --> ... retiring from the partnership at TPG Capital, one of ... over $140 Billion in revenue.  He founded and led ... the TPG companies, from 1997 to 2013.  In his ...
(Date:11/12/2015)... 2015  Arxspan has entered into an agreement ... for use of its ArxLab cloud-based suite of ... partnership will support the institute,s efforts to electronically ... information internally and with external collaborators. The ArxLab ... the Institute,s electronic laboratory notebook, compound and assay ...
Breaking Biology News(10 mins):